Harmony Biosciences Set to Share Insights at Upcoming Investor Conferences
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), a leading developer of treatments for rare neurological diseases, has announced its upcoming participation in two significant investor conferences. The …
Harmony Biosciences Set to Share Insights at Upcoming Investor Conferences Read More